SURGICAL AORTIC VALVE REPLACEMENT - SINGLE OPERATOR EXPERIENCE

Volume : VII, Issue : VIII, August - 2018

Mariappan Balaiah, Gnanavelu Ganesan

Aortic valve is the second most affected valve in developing countries. Given the increasing life expectancy of population in our

country, degenerative aortic valve disease may supersede the causes of aortic valve disease like congenital defects and rheumatic

heart disease over next two decades. Stenosis, regurgitation or combination of both can lead to significant hemodynamic

compromise and affect the quality of life of the patient. Once symptoms develop, the prognosis of aortic valve disease becomes

bad. Aortic valve replacement either with mechanical valve or bio–prosthetic valve is the treatment of choice. SAVR (Surgical

aortic valve replacement) and TAVR (Transcatheter aortic valve replacement) are available to selected patients with degenerative

calcific aortic stenosis, depending on age, clinical status and co–morbid conditions. However SAVR is indicated in all other

conditions, those with aortic stenosis and regurgitation, isolated aortic regurgitation, congenital defect of aortic valve and also if

aortic valve disease coexists with other defects like mitral valve disease, septal defects, aortic root aneurysm etc. In this study, the

experience and outcome of SAVR by the author is analyzed and compared with the data available worldwide. Mortality rate

(2.5%) and other rates of complications and the need for permanent pacemaker implantation (2.5%) are comparable to the

results found in literature.